Cargando…
Ovarian Cancer Gene Therapy Using HPV-16 Pseudovirion Carrying the HSV-tk Gene
Ovarian cancer is the leading cause of death from all gynecological cancers and conventional therapies such as surgery, chemotherapy, and radiotherapy usually fail to control advanced stages of the disease. Thus, there is an urgent need for alternative and innovative therapeutic options. We reason t...
Autores principales: | Hung, Chien-Fu, Chiang, An Jen, Tsai, Hsiao-Hsuan, Pomper, Martin G., Kang, Tae Heung, Roden, Richard R., Wu, T.-C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3398866/ https://www.ncbi.nlm.nih.gov/pubmed/22815887 http://dx.doi.org/10.1371/journal.pone.0040983 |
Ejemplares similares
-
Efficient Delivery of DNA Vaccines using Human Papillomavirus Pseudovirions
por: Peng, Shiwen, et al.
Publicado: (2010) -
Efficacy of HSV-TK/GCV system suicide gene therapy using SHED expressing modified HSV-TK against lung cancer brain metastases
por: Oishi, Tomoya, et al.
Publicado: (2022) -
Vimentin Modulates Infectious Internalization of Human Papillomavirus 16 Pseudovirions
por: Schäfer, Georgia, et al.
Publicado: (2017) -
Bystander-Mediated Regression of Murine Neuroblastoma via Retroviral Transfer of the HSV-TK Gene
por: Cho, Hyun-Sang, et al.
Publicado: (2004) -
Gene Therapy with HSV1-sr39TK/GCV Exhibits a Stronger Therapeutic Efficacy Than HSV1-TK/GCV in Rat C6 Glioma Cells
por: Li, Lei-qing, et al.
Publicado: (2013)